Outliers and Patients with Adverse Drug Reactions

ISSN： 0114-5916

Source： Drug Safety, Vol.32, Iss.8, 2009-08, pp. : 623-624

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Patients’ role in reporting adverse drug reactions

By van Grootheest Kees de Jong-van den Berg Lolkje

Expert Opinion on Drug Safety, Vol. 3, Iss. 4, 2004-07 ,pp. : 363-368

Informa Healthcare

Access to resources Recommend Favorite

Frequency and Preventability of Adverse Drug Reactions in Paediatric Patients

By Mary E. Temple Renee F. Robinson Julie C. Miller John R. Hayes Milap C. Nahata

Drug Safety, Vol. 27, Iss. 11, 2004-01 ,pp. : 819-829

Adis International

Access to resources Recommend Favorite

The Risk of Adverse Drug Reactions in Older Patients: Beyond Drug Metabolism

Current Drug Metabolism, Vol. 12, Iss. 7, 2011-09 ,pp. : 647-651

Bentham Science Publishers

Access to resources Recommend Favorite

The cost of adverse drug reactions

By Gautier Sophie Bachelet Hélène Bordet Régis Caron Jacques

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 3, 2003-03 ,pp. : 319-326

Informa Healthcare

Access to resources Recommend Favorite

Ocular adverse drug reactions

By Fraunfelder FW

Expert Opinion on Drug Safety, Vol. 2, Iss. 4, 2003-07 ,pp. : 411-420

Informa Healthcare

Access to resources Recommend Favorite